---
title: "YZYBIO-B granted a total of 3.55 million stock options"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242015593.md"
description: "According to the announcement from YZYBIO-B, on May 27, 2025, a total of 3.55 million stock options will be granted to four eligible participants under the terms of the 2024 H-share stock option plan, allowing for the subscription of 3.55 million H shares, but it must be confirmed after the grantees accept the stock options"
datetime: "2025-05-27T12:21:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242015593.md)
  - [en](https://longbridge.com/en/news/242015593.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242015593.md)
generator: "portal-rs"
---

# YZYBIO-B granted a total of 3.55 million stock options

According to the announcement from YZYBIO-B (02496) on the Zhitong Finance APP, on May 27, 2025, a total of 3.55 million stock options will be granted to four eligible participants under the terms of the 2024 H-share stock option plan, allowing for the subscription of 3.55 million H-shares, but this will only take effect after the grantees accept the stock options

### Related Stocks

- [02496.HK](https://longbridge.com/en/quote/02496.HK.md)

## Related News & Research

- [RemeGen files board, board committee member list with disclosure responsibilities](https://longbridge.com/en/news/296803857.md)
- [Abbisko Cayman seeks name change to Abbisko Medicine Co](https://longbridge.com/en/news/296795772.md)
- [Brii Biosciences files HKEX next-day disclosure, lifts share capital by 255,793 shares](https://longbridge.com/en/news/296801683.md)
- [Abbisko turns to IFRS net loss of RMB 193.47 million in FY26 H1; revenue drops 84% to RMB 97.27 million](https://longbridge.com/en/news/296795302.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**